Peptidyl-lysine dimethylation

pathway activity — cross-omics
GO:0018027Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Peptidyl-lysine dimethylation pathway is significantly associated with the protein abundance of multiple proteins, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are LTBP4, SMARCC2, and BRD3, each associated with the pathway in up to 8 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Peptidyl-lysine dimethylation activity versus LTBP4 in CCRCC (Pearson r = 0.15).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCLTBP4 →+0.600+0.028.002.00338
GBMSMARCC2 →+0.331+0.051<.001.00237
GBMBRD3 →+0.425+0.063<.001<.00137
GBMSPEN_S1006 →+0.378+0.059.003<.00136
GBMSPIN1 →+0.321+0.051<.001<.00136
GBMTSHZ1_S671 →+0.487+0.057.005<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0018027 vs LTBP4 — CCRCC

Per-sample scatter of Peptidyl-lysine dimethylation activity vs LTBP4 in CCRCC.

Explore this scatter interactively →

Exploration